A historical, evidence-based, and narrative review on commonly used dietary supplements in lipid-lowering

被引:1
|
作者
Grant, Jelani K. [1 ]
Dangl, Michael [2 ]
Ndumele, Chiadi E. [1 ]
Michos, Erin D. [1 ]
Martin, Seth S. [1 ]
机构
[1] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiovasc Dis, Div Cardiol, Sch Med, Baltimore, MD 21205 USA
[2] Univ Miami, Jackson Mem Hosp, Internal Med Dept, Miller Sch Med, Miami, FL USA
基金
美国国家卫生研究院;
关键词
dietary supplements; fish oil; supplements; lipids; inflammation; lipid lowering; RANDOMIZED CONTROLLED-TRIALS; EICOSAPENTAENOIC ACID; FISH CONSUMPTION; CORONARY EVENTS; ICOSAPENT ETHYL; RISK-FACTORS; FATTY-ACIDS; METAANALYSIS; MARKERS; SAFETY;
D O I
10.1016/j.jlr.2023.100493
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dietary supplements augment the nutritional value of everyday food intake and originate from the historical practices of ancient Egyptian herbalists. In modern-day medicine, the use of dietary supplements continues to increase in popularity with greater than 50% of the US population reporting taking supplements. To further compound this trend, many patients believe that dietary supplements are equally or more effective than evidence-based therapies for lipoprotein and lipid-lowering. Supplements such as red yeast rice, omega-3 fatty acids, garlic, cinnamon, plant sterols, and turmeric are marketed to and believed by consumers to promote "cholesterol health." However, these supplements are not subjected to the same manufacturing scrutiny by the Food and Drug Administration as pharmaceutical drugs and as such, the exact contents and level of ingredients in each of these may vary. Furthermore, supplements do not have to demonstrate efficacy or safety before being marketed. The holistic approach to lowering atherosclerotic cardiovascular disease risk makes dietary supplements an attractive option to many patients; however, their use should not come at the expense of established therapies with proven benefits. In this narrative review, we provide a historical and evidence-based approach to the use of some dietary supplements in lipoprotein and lipidlowering and provide a framework for managing patient expectations.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] An evidence-based review of commonly used dietary supplements
    Laird, John
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2015, 28 (07):
  • [2] Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects
    Cicero, Arrigo F. G.
    Ferroni, Alienor
    Ertek, Sibel
    [J]. EXPERT OPINION ON DRUG SAFETY, 2012, 11 (05) : 753 - 766
  • [3] Are lipid-lowering guidelines evidence-based?
    Abramson, J.
    Wright, J. M.
    [J]. LANCET, 2007, 369 (9557): : 168 - 169
  • [4] Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements-A Narrative Review
    Zivkovic, Stefan
    Maric, Gorica
    Cvetinovic, Natasa
    Lepojevic-Stefanovic, Danijela
    Bozic Cvijan, Bojana
    [J]. NUTRIENTS, 2023, 15 (06)
  • [5] Lipid-Lowering Therapies: Risks in Women and Evidence-Based Options
    Shah, Tina
    Virani, Salim S.
    [J]. TEXAS HEART INSTITUTE JOURNAL, 2018, 45 (04): : 238 - 239
  • [6] Lipid-Lowering Medications for Managing Dyslipidemia: A Narrative Review
    Alqahtani, Majed S.
    Alzibali, Khalid F.
    Mahdi, Abdulaziz Mahdi M.
    Alharbi, Osama Mohammed A.
    Harbi, Reem Hafiz A.
    Alkhaldi, Hamad Saad M.
    Alsayafi, Zahrah Ali A.
    Albisher, Fatema H.
    Buqurayn, Murtadha H.
    Alharbi, Meshal M.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [7] Lipids, Lipid-Lowering Therapy, and Neuropathy: A Narrative Review
    Pasha, Raabya
    Azmi, Shazli
    Ferdousi, Maryam
    Kalteniece, Alise
    Bashir, Bilal
    Gouni-Berthold, Ioanna
    Malik, Rayaz A.
    Soran, Handrean
    [J]. CLINICAL THERAPEUTICS, 2022, 44 (07) : 1012 - 1025
  • [8] Clinical evidence - An evidence-based review of the to most commonly used herbs
    Mar, C
    Bent, S
    [J]. WESTERN JOURNAL OF MEDICINE, 1999, 171 (03): : 168 - 171
  • [9] Evidence-Based Adherence Classes for Combination Antihypertensive, Lipid-Lowering, and Antidiabetic Therapy
    Davis, James
    Starr, Ranjani
    Juarez, Deborah T.
    [J]. AMERICAN JOURNAL OF PHARMACY BENEFITS, 2015, 7 (04) : E108 - E115
  • [10] Evidence-based interventions to improve patient compliance with antihypertensive and lipid-lowering medications
    Petrilla, AA
    Benner, JS
    Battleman, DS
    Tierce, JC
    Hazard, EH
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (12) : 1441 - 1451